Complex Trait Classification with Rare Variant Gene Burden Scores

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods struggle to identify and classify the genetic patterns underlying complex human traits and disorders, particularly those influenced by rare variants with low minor allele frequency, which are difficult to detect and analyze due to their rarity and lack of statistical significance in traditional genome-wide association studies.

Innovation Solution

A computational classification model is trained using genetic data from cohorts with and without complex disorders to identify a minimal set of genes with variant patterns, utilizing a penalized linear classification model like LASSO to determine an individual's propensity for a disorder based on aggregated variant burden scores, including rare variants, and optionally incorporating health record data.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If traditional genome-wide association studies are used to identify genetic variants, then common variants can be detected, but rare variants with low minor allele frequency cannot be statistically significant

Engineering Contradiction:
Improvedetection accuracy of rare variantsVSAvoidstatistical significance
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The patent combines multiple rare variants within the same gene into an aggregate burden score. Instead of evaluating each rare variant individually (which lacks statistical power), the method aggregates the effects of multiple rare variants across a gene, thereby achieving statistical significance while maintaining detection accuracy for rare variants.

Inventive Principle:
Principle #5Merging (Combining)

2Area of stationary object

If genome-wide association studies examine the entire genome, then comprehensive genetic coverage is achieved, but the complexity and computational burden increase

Engineering Contradiction:
Improvegenetic coverageVSAvoidcomputational complexity
Core Design Contradiction:
Area of stationary objectVSDevice complexity

Solution Approach 1:

The patent extracts and focuses analysis on specific genes that are pre-identified as potentially relevant to the complex trait or disorder. Rather than analyzing the entire genome, the method extracts and evaluates only the variant burden within selected genes, thereby maintaining comprehensive genetic coverage of relevant regions while significantly reducing computational complexity.

Inventive Principle:
Principle #2Taking out (Extraction)

3Reliability

If a large number of cohort individuals are used in traditional GWAS, then statistical power increases, but the required sample size becomes prohibitively large for rare variants

Engineering Contradiction:
Improvestatistical powerVSAvoidcohort sample size
Core Design Contradiction:
ReliabilityVSQuantity of substance

Solution Approach 1:

By merging multiple rare variants into an aggregate burden score within each gene, the patent increases statistical power without requiring a proportionally large increase in cohort sample size. The aggregation approach allows the method to achieve reliable detection of rare variant contributions with more manageable cohort sizes compared to traditional GWAS.

Inventive Principle:
Principle #5Merging (Combining)

4Measurement precision

If computational models incorporate multiple genes and variants, then classification accuracy improves, but the model complexity increases

Engineering Contradiction:
Improveclassification accuracyVSAvoidmodel complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent segments the complex genetic analysis into discrete gene-level burden scores. Instead of analyzing all variants simultaneously across the genome (which would be computationally intensive), the method divides the problem into manageable segments (individual genes), calculates burden scores for each segment, and then integrates these segments into the final classification model, thereby improving accuracy while controlling complexity.

Inventive Principle:
Principle #1Segmentation

Data Source

PatentUS12387816B2Processes for genetic and clinical data evaluation and classification of complex human traits
Publication Date: 2025.08.12 THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIV
  • US12387816B2 patent drawing
  • US12387816B2 patent drawing
  • US12387816B2 patent drawing

AI summary

Processes to identify a subset of trait-related genes and classify individuals are described. Generally, systems generate classification models which are used to identify the subset of trait-related genes and classify individuals. The classification models are also used in various applications, including developing research tools, performing diagnostics, and treating individuals.